DOM Grand Rounds: CAR T-Cells and Cancer Immunogenetics - Towards Personalized Therapies

| 12:00 PM - 01:00 PM

Join us for DOM Grand Roujnds “CAR T-Cells and Cancer Immunogenetics – Towards Personalized Therapies”

Wednesday, October 20 from 12:00-1:00pm

Join:  https://ucdenver.zoom.us/j/93273540118

You will be prompted for your name and email address
Webinar ID: 932 7354 0118

By Phone: US: +1 669 900 6833 or +1 346 248 7799 
CAR T-Cells and Cancer Immunogenetics - Towards Personalized Therapies








During the Q&A portion, questions may be submitted using the Q/A feature in Zoom.  Due to time and other logistical limitations, we cannot guarantee that all submitted questions will be posed.

Missed Grand Rounds? View past DOM Grand Rounds videos: http://bit.ly/CUMedGRArchives

 

Full schedule of upcoming DOM Grand Rounds events and downloadable appointments: http://bit.ly/CUMedGrandRounds

 

Accreditation & Designation Statement: The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Dr. Smith reports a relevant financial relationship with research funding from Argenix, Kura, Syros & United Health Group.  Dr. Fry reports a relevant financial relationship of employment with Sana Biotechnology. All of the relevant financial relationships listed for these individuals have been mitigated. All of the other planners, faculty, or individuals in control of content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Add event to:

DOM Grand Rounds: CAR T-Cells and Cancer Immunogenetics - Towards Personalized Therapies

| 12:00 PM - 01:00 PM

Join us for DOM Grand Roujnds “CAR T-Cells and Cancer Immunogenetics – Towards Personalized Therapies”

Wednesday, October 20 from 12:00-1:00pm

Join:  https://ucdenver.zoom.us/j/93273540118

You will be prompted for your name and email address
Webinar ID: 932 7354 0118

By Phone: US: +1 669 900 6833 or +1 346 248 7799 
CAR T-Cells and Cancer Immunogenetics - Towards Personalized Therapies








During the Q&A portion, questions may be submitted using the Q/A feature in Zoom.  Due to time and other logistical limitations, we cannot guarantee that all submitted questions will be posed.

Missed Grand Rounds? View past DOM Grand Rounds videos: http://bit.ly/CUMedGRArchives

 

Full schedule of upcoming DOM Grand Rounds events and downloadable appointments: http://bit.ly/CUMedGrandRounds

 

Accreditation & Designation Statement: The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Dr. Smith reports a relevant financial relationship with research funding from Argenix, Kura, Syros & United Health Group.  Dr. Fry reports a relevant financial relationship of employment with Sana Biotechnology. All of the relevant financial relationships listed for these individuals have been mitigated. All of the other planners, faculty, or individuals in control of content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Add event to: